You are here: Industry Insights > medicines

News List

No-deal Brexit could mean temporary medicines export ban pharmatimes
April 02, 2019
The Association of the British Pharmaceutical Industry (ABPI) has called for a temporary ban on drugs exports in the event of a no-deal Brexit to prevent the NHS being hit by shortages.
EMA’s CHMP meeting recommends eight medicines for approval pharmaceutical-technology
March 05, 2019
The European Medical Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has recommended eight medicines for approval at its February meeting...
FDA Expands Indication for Soliqua® 100/33 americanpharmaceuticalreview
March 01, 2019
The U.S. Food and Drug Administration (FDA) has approved the expanded use of Soliqua® 100/33 (insulin glargine and lixisenatide injection) 100 Units/mL and 33 mcg/mL.
Public consultation on key principles for ePI of EU medicines europeanpharmaceuticalreview
February 02, 2019
The European Medicine Agency, the Heads of Medicines Agencies (HMA) and the European Commission (EC) are launching a six-month public consultation on draft key principles...
Global Medicine spending to exceeds $1.5 Tn by 2023 biospectrumasia
February 01, 2019
Opioid prescriptions per capita in the US are estimated to decline by one-half to one-third compared to current levels by 2023.
Proposed Medicare reforms spark comments about drugs europeanpharmaceuticalreview
January 31, 2019
The Centers for Medicare and Medicaid Services, part of the Department of Health and Human Services has proposed a reform titled “Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses.”
Pharma industry ‘call for action’ following Brexit vote europeanpharmaceuticalreview
January 17, 2019
The pharma industry has called for the government to act to ensure that patients receive their medications in the case of a ‘no deal’ situation…
BMS receives offer from Taisho to purchase UPSA cphi-online
January 02, 2019
The potential transaction would position BMS to further refine its portfolio to focus on transformational medicines for patients facing serious diseases.
Amgen, Direct Relief Partner to help cancer patients In 18 countries biospectrumasia
December 17, 2018
The first shipments of the nearly 110,000 units of donated medicines have already reached cancer clinics in destination countries and are available to patients
Licences for manufacturers and wholesalers of medicines and ingredients europeanpharmaceuticalreview
December 13, 2018
Updated public list of companies in the UK who have had their licence/registration to manufacture or wholesale medicines/ingredients revoked or suspended…

Previous page 1 2 3 4 5 6 7 8 9 10 Next page